<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="44684">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02524587</url>
  </required_header>
  <id_info>
    <org_study_id>09-113</org_study_id>
    <nct_id>NCT02524587</nct_id>
  </id_info>
  <brief_title>Study of the Wear of a Highly Cross-linked Polyethylene Acetabular Doped With Vitamin E and Coated With Titanium in Total Hip Replacement</brief_title>
  <acronym>POLYTITAN</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The total hip replacement, with over 120,000 cases per year in France, provides short term,
      excellent functional results and a significant improvement in quality of life, in almost all
      cases. However, the observation has shown that the lifetime of the implants is limited due
      to aseptic loosening. One of the factors associated with these failures is a peri-prosthetic
      osteolysis wherein the polyethylene wear debris (PE) have been implicated. Several solutions
      have been proposed: change the friction torque (hard-hard pairs using ceramic or metal on
      the two components of the couple) or improving quality polyethylene. Improving the
      resistance of polyethylene wear is the primary objective evaluated in this study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2010</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>penetration of the metal femoral head in acetabular</measure>
    <time_frame>2 years</time_frame>
    <description>head penetration in milimeters</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Total Hip Replacement</condition>
  <arm_group>
    <arm_group_label>acetabular polyethylene vitamys®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>acetabular polyethylene vitamys®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard polyethylene acetabular irradiated at 3 Mrad</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard polyethylene acetabular irradiated at 3 Mrad</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>standard polyethylene acetabular irradiated at 3 Mrad</intervention_name>
    <arm_group_label>standard polyethylene acetabular irradiated at 3 Mrad</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>radio stereometric analysis (RSA) of the acetabular</intervention_name>
    <arm_group_label>acetabular polyethylene vitamys®</arm_group_label>
    <arm_group_label>standard polyethylene acetabular irradiated at 3 Mrad</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>acetabular polyethylene vitamys®</intervention_name>
    <arm_group_label>acetabular polyethylene vitamys®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged men and women 18 to 75 years

          -  with a primary or secondary osteoarthritis or osteonecrosis

          -  having a functional disorder requiring the installation of a total hip prosthesis of
             primary

        Exclusion Criteria:

          -  patients aged 76 years or more

          -  pregnant or desiring to be for the duration of the study

          -  minors or adults protected

          -  repeated hip replacement

          -  cephalic prosthesis recovery or intermediate

          -  repeated cupules

          -  primary or secondary malignant tumor of the hip
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Département d'orthopédie - traumatologie, CHU de Caen</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benoit LEBEL</last_name>
      <phone>02.31.06.46.61</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>August 13, 2015</lastchanged_date>
  <firstreceived_date>August 6, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
